A Single-Arm Phase II Trial of Weekly Nanoparticle Albumin-Bound Paclitaxel Monotherapy After Standard Therapy for Advanced NSCLC

被引：0
|
作者：
Kato, Y. [1 ]
Okuma, Y. [1 ]
Hosomi, Y. [1 ]
机构：
[1] Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Advanced non-small cell lung cancer; Nab-paclitaxel; Later-line setting;
D O I：
10.1016/j.jtho.2019.08.1995
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1.01-20
引用
收藏
页码：S919 / S920
页数：2
相关论文
共 50 条
  • [1] A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small cell lung cancer
    Yasuhiro Kato
    Yusuke Okuma
    Kageaki Watanabe
    Makiko Yomota
    Shoko Kawai
    Yukio Hosomi
    Tatsuru Okamura
    [J]. Cancer Chemotherapy and Pharmacology, 2019, 84 : 351 - 358
  • [2] A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small cell lung cancer
    Kato, Yasuhiro
    Okuma, Yusuke
    Watanabe, Kageaki
    Yomota, Makiko
    Kawai, Shoko
    Hosomi, Yukio
    Okamura, Tatsuru
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (02) : 351 - 358
  • [3] Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLC
    Yoneshima, Yasuto
    Morita, Satoshi
    Ando, Masahiko
    Nakamura, Atsushi
    Iwasawa, Shunichiro
    Yoshioka, Hiroshige
    Goto, Yasuhiro
    Takeshita, Masafumi
    Harada, Toshiyuki
    Hirano, Katsuya
    Oguri, Tetsuya
    Kondo, Masashi
    Miura, Satoru
    Hosomi, Yukio
    Kato, Terufumi
    Kubo, Toshio
    Kishimoto, Junji
    Yamamoto, Nobuyuki
    Nakanishi, Yoichi
    Okamoto, Isamu
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (09) : 1523 - 1532
  • [4] Camrelizumab combined with apatinib and nanoparticle albumin-bound paclitaxel in lung adenocarcinoma (CAPAP-lung): a single-arm phase II study
    Pu, Xingxiang
    Lin, Gen
    Xiao, Maoliang
    Lin, Jie
    Wang, Qianzhi
    Kong, Yi
    Yan, Xuejun
    Xu, Fang
    Xu, Yan
    Li, Jia
    Li, Kang
    Chen, Bolin
    Wen, Xiaoping
    Tan, Yali
    Cheng, Fengzhuo
    Zhu, Kangle
    Li, Na
    Wu, Lin
    [J]. ECLINICALMEDICINE, 2024, 67
  • [5] A phase II, multicenter, single-arm study of tri-weekly low-dose nanoparticle albumin-bound paclitaxel chemotherapy for patients with metastatic or recurrent breast cancer
    Shigeru Yamamoto
    Noriko Maeda
    Yukiko Nagashima
    Hidefumi Kubo
    Yoko Sato
    Hiroto Matsui
    Yuka Inoue
    Yoshitaro Shindo
    Shinsuke Kanekiyo
    Kazuhiko Sakamoto
    Nobuaki Suzuki
    Shigeru Takeda
    Tomio Ueno
    Shigefumi Yoshino
    Shoichi Hazama
    Masaaki Oka
    Hiroaki Nagano
    [J]. Breast Cancer, 2017, 24 : 783 - 789
  • [6] A phase II, multicenter, single-arm study of tri-weekly low-dose nanoparticle albumin-bound paclitaxel chemotherapy for patients with metastatic or recurrent breast cancer
    Yamamoto, Shigeru
    Maeda, Noriko
    Nagashima, Yukiko
    Kubo, Hidefumi
    Sato, Yoko
    Matsui, Hiroto
    Inoue, Yuka
    Shindo, Yoshitaro
    Kanekiyo, Shinsuke
    Sakamoto, Kazuhiko
    Suzuki, Nobuaki
    Takeda, Shigeru
    Ueno, Tomio
    Yoshino, Shigefumi
    Hazama, Shoichi
    Oka, Masaaki
    Nagano, Hiroaki
    [J]. BREAST CANCER, 2017, 24 (06) : 783 - 789
  • [7] The role of weekly nanoparticle albumin bound paclitaxel monotherapy as second line or later treatment for advanced NSCLC in China
    Xing, Puyuan
    Zhu, Yixiang
    Shan, Ling
    Chen, Sipeng
    Hao, Xuezhi
    Li, Junling
    [J]. ONCOTARGET, 2017, 8 (50) : 87442 - 87454
  • [8] Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial*
    Adkins, Douglas
    Ley, Jessica
    Atiq, Omar
    Powell, Steven
    Spanos, William C.
    Gitau, Mark
    Rigden, Caron
    Palka, Kevin
    Liu, Jingxia
    Oppelt, Peter
    [J]. ORAL ONCOLOGY, 2021, 115
  • [9] A Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel With or Without Trastuzumab in Metastatic Breast Cancer
    Mirtsching, Barry
    Cosgriff, Thomas
    Harker, Graydon
    Keaton, Mark
    Chidiac, Tarek
    Min, Myo
    [J]. CLINICAL BREAST CANCER, 2011, 11 (02) : 121 - 128
  • [10] Phase I study of combination therapy with weekly nanoparticle albumin-bound paclitaxel and cyclophosphamide in patients with advanced or recurrent breast cancer
    Ota, D.
    Akatsuka, S.
    Nishi, T.
    Kato, T.
    Takeuchi, M.
    Munechika, T.
    Inagaki, M.
    Fukuuchi, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S283 - S283
12345